¼¼°èÀÇ Á¤¸Æ ½Ã¼ú ±â±â ½ÃÀå
Venous Procedure Devices
»óǰÄÚµå : 1796047
¸®¼­Ä¡»ç : Global Industry Analysts, Inc.
¹ßÇàÀÏ : 2025³â 08¿ù
ÆäÀÌÁö Á¤º¸ : ¿µ¹® 474 Pages
 ¶óÀ̼±½º & °¡°Ý (ºÎ°¡¼¼ º°µµ)
US $ 5,850 £Ü 8,233,000
PDF & Excel (Single User License) help
PDF & Excel º¸°í¼­¸¦ 1¸í¸¸ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. ÆÄÀÏ ³» ÅØ½ºÆ®ÀÇ º¹»ç ¹× ºÙ¿©³Ö±â´Â °¡´ÉÇÏÁö¸¸, Ç¥/±×·¡ÇÁ µîÀº º¹»çÇÒ ¼ö ¾ø½À´Ï´Ù. Àμâ´Â 1ȸ °¡´ÉÇϸç, Àμ⹰ÀÇ ÀÌ¿ë¹üÀ§´Â ÆÄÀÏ ÀÌ¿ë¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.
US $ 17,550 £Ü 24,701,000
PDF & Excel (Global License to Company and its Fully-owned Subsidiaries) help
PDF & Excel º¸°í¼­¸¦ µ¿ÀÏ ±â¾÷ ¹× 100% ÀÚȸ»çÀÇ ¸ðµç ºÐÀÌ ÀÌ¿ëÇÏ½Ç ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμâ´Â 1Àδç 1ȸ °¡´ÉÇϸç, Àμ⹰ÀÇ ÀÌ¿ë¹üÀ§´Â ÆÄÀÏ ÀÌ¿ë¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.


Çѱ۸ñÂ÷

Á¤¸Æ ½Ã¼ú ±â±â ¼¼°è ½ÃÀåÀº 2030³â±îÁö 37¾ï ´Þ·¯¿¡ ´ÞÇÒ Àü¸Á

2024³â¿¡ 26¾ï ´Þ·¯·Î ÃßÁ¤µÇ´Â Á¤¸Æ ½Ã¼ú ±â±â ¼¼°è ½ÃÀåÀº 2024-2030³â ºÐ¼® ±â°£ µ¿¾È CAGR 5.7%·Î ¼ºÀåÇÏ¿© 2030³â¿¡´Â 37¾ï ´Þ·¯¿¡ ´ÞÇÒ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù. ÀÌ º¸°í¼­¿¡¼­ ºÐ¼®ÇÑ ºÎ¹® Áß ÇϳªÀÎ Ä«Å×ÅÍ´Â CAGR 6.7%¸¦ ±â·ÏÇÏ¸ç ºÐ¼® ±â°£ Á¾·á½Ã¿¡´Â 23¾ï ´Þ·¯¿¡ ´ÞÇÒ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù. °¡À̵å¿ÍÀÌ¾î ºÎ¹®ÀÇ ¼ºÀå·üÀº ºÐ¼® ±â°£ µ¿¾È CAGR 3.9%·Î ÃßÁ¤µË´Ï´Ù.

¹Ì±¹ ½ÃÀåÀº 7¾ï 1,850¸¸ ´Þ·¯, Áß±¹Àº CAGR 9.2%·Î ¼ºÀå ¿¹Ãø

¹Ì±¹ÀÇ Á¤¸Æ ½Ã¼ú ±â±â ½ÃÀåÀº 2024³â¿¡ 7¾ï 1,850¸¸ ´Þ·¯·Î ÃßÁ¤µË´Ï´Ù. ¼¼°è 2À§ °æÁ¦ ´ë±¹ÀÎ Áß±¹Àº 2024³âºÎÅÍ 2030³â ºÐ¼® ±â°£ µ¿¾È CAGR 9.2%·Î ¼ºÀåÇÏ¿© 2030³â¿¡´Â 7¾ï 4,920¸¸ ´Þ·¯ÀÇ ½ÃÀå ±Ô¸ð¿¡ ´ÞÇÒ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù. ±âŸ ÁÖ¸ñÇÒ ¸¸ÇÑ Áö¿ªº° ½ÃÀåÀ¸·Î´Â ÀϺ»°ú ij³ª´Ù°¡ ÀÖ°í, ºÐ¼® ±â°£ µ¿¾È CAGRÀº °¢°¢ 2.7%¿Í 5.6%·Î ¿¹ÃøµË´Ï´Ù. À¯·´¿¡¼­´Â µ¶ÀÏÀÌ CAGR 3.7%·Î ¼ºÀåÇÒ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù.

¼¼°èÀÇ Á¤¸Æ ½Ã¼ú ±â±â ½ÃÀå - ÁÖ¿ä µ¿Çâ°ú ÃËÁø¿äÀÎ Á¤¸®

Á¤¸Æ Ä¡·á ±â±â°¡ ¿©·¯ Àü¹® ºÐ¾ß¿¡¼­ ¼ö¿ä°¡ Áõ°¡ÇÏ´Â ÀÌÀ¯´Â ¹«¾ùÀΰ¡?

¸¸¼ºÁ¤¸ÆºÎÀü(CVI), ½ÉºÎÁ¤¸ÆÇ÷ÀüÁõ(DVT), Á¤¸Æ·ù, Á¤¸Æ±Ë¾ç Ä¡·á¿¡ »ç¿ëµÇ´Â ±â¼úÀ» Æ÷°ýÇÏ´Â Á¤¸Æ ½Ã¼ú ±â±â´Â Àα¸ °í·ÉÈ­, ÁÂ½Ä »ýȰ½À°ü, Ç÷°ü Áúȯ ¹ß»ý·ü Áõ°¡·Î ÀÎÇØ ¼ö¿ä°¡ ´Ù½Ã Áõ°¡Çϰí ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ ±â±â¿¡´Â °íÁÖÆÄ ¹× ·¹ÀÌÀú ¼ÒÀÛ Ä«Å×ÅÍ, °æÈ­¿ä¹ý ŰƮ, Á¤¸Æ ½ºÅÙÆ®, Ç÷ÀüÁ¦°Å ±â±â, ¾Ð¹Ú ½Ã½ºÅÛ µîÀÌ ÀÖÀ¸¸ç, ¸ðµÎ Á¤¸Æ ȯ·ù¸¦ °³¼±Çϰí ÇÕº´ÁõÀ» ¿¹¹æÇϱâ À§ÇÑ ÃÖ¼Òħ½ÀÀû ÁßÀ縦 Áö¿øÇÕ´Ï´Ù. ÀÓ»ó µµÀÔÀº Ç÷°ü¿Ü°ú, ÀÎÅͺ¥¼Ç ¿µ»óÀÇÇаú, ÇǺΰú µîÀ¸·Î È®´ëµÇ°í ÀÖ½À´Ï´Ù.

ƯÈ÷ Àü ¼¼°è º´¿ø¿¡¼­ ¿¹¹æ °¡´ÉÇÑ »ç¸ÁÀÇ ÁÖ¿ä ¿øÀÎÀÎ Á¤¸ÆÇ÷Àü»öÀüÁõ(VTE)ÀÇ À¯º´·ü Áõ°¡°¡ °­·ÂÇÑ ¼ºÀå ¿äÀÎÀ¸·Î ÀÛ¿ëÇϰí ÀÖ½À´Ï´Ù. ¿µ»ó Áø´ÜÀÇ Áõ°¡, Ç÷ÀüÈÄÁõÈıº(PTS)¿¡ ´ëÇÑ ÀνÄ, ÀÇ·Ú °æ·ÎÀÇ °³¼±À¸·Î Ä¡·á °¡´ÉÇÑ È¯ÀÚÃþÀÌ È®´ëµÇ°í ÀÖ½À´Ï´Ù. ÀÌ¿Í ÇÔ²² »ç¹«½Ç ±â¹Ý ½Ã¼ú ¹× ¿Ü·¡ ȯÀÚ È¯°æÀÇ ¹ßÀüÀº ÈÞ´ë¿ë ¿µ»ó À¯µµ ÀýÁ¦ ½Ã½ºÅÛ ¹× ÀÏȸ¿ë Ä«Å×ÅÍ Å°Æ®¿¡ ´ëÇÑ ¼ö¿ä¸¦ ÃËÁøÇϰí ÀÖ½À´Ï´Ù. ¼ÒºñÀÚ ÁÖµµÀÇ ¹ÌÀû °¨°¢°ú »îÀÇ Áú¿¡ ´ëÇÑ °ü½Éµµ ¹Ì¿ë Á¤¸Æ·ù Á¦°Å¿¡ ´ëÇÑ ¼ö¿ä¸¦ Áõ°¡½ÃÄÑ Á¤¸Æ ±â±âÀÇ ÀÓ»óÀû Àü¸ÁÀ» ´õ¿í ³ÐÈ÷°í ÀÖ½À´Ï´Ù.

±â±â ¼³°èÀÇ Çõ½ÅÀº ¾î¶»°Ô ½Ã¼úÀÇ È¿À²¼º°ú Ä¡·á °á°ú¸¦ °³¼±Çϰí Àִ°¡?

Á¤¸Æ ½Ã¼ú ±â±âÀÇ ±â¼ú ¹ßÀüÀº ȯÀÚÀÇ Æí¾ÈÇÔÀ» °³¼±Çϰí, Àç¹ß·üÀ» ³·Ã߸ç, ºü¸¥ ȸº¹À» °¡´ÉÇÏ°Ô ÇÏ´Â µ¥ ÁßÁ¡À» µÎ°í ÀÖ½À´Ï´Ù. Â÷¼¼´ë Á¤¸Æ ³» ¼ÒÀÛ¼ú ½Ã½ºÅÛÀº ¿­ ¼Õ»óÀ» ÃÖ¼ÒÈ­Çϱâ À§ÇØ ÅëÇÕµÈ ³Ã°¢ ¹× Çǵå¹é ¸ÞÄ¿´ÏÁòÀ» °®Ãß°í ÀÖÀ¸¸ç, ¹ÙÀÌÆú¶ó °íÁÖÆÄ¿Í ¼¶À¯ Àü´Þ ·¹ÀÌÀú ¿¡³ÊÁö¸¦ »ç¿ëÇÏ¿© ºÎÀü Á¤¸ÆÀÇ Á¤¹ÐÇÑ ¿­ Æó¼â¸¦ À§ÇÑ ·¹ÀÌÀú ¿¡³ÊÁö¸¦ »ç¿ëÇÕ´Ï´Ù. ±â°èÀû Àڱذú °æÈ­Á¦ ÁÖÀÔÀ» °áÇÕÇÑ ±â°èÈ­ÇÐÀýÁ¦¼ú(MOCA) ½Ã½ºÅÛÀº ºñ¿­ÀûÀÌ°í ¸¶Ãë°¡ ÇÊ¿ä ¾ø´Ù´Â ÀåÁ¡°ú ±¼°îÁø Á¤¸Æ ÇØºÎÇÐÀû ±¸Á¶¿¡ ´ëÇÑ ÀûÇÕ¼ºÀ¸·Î ÀÎÇØ äÅÃÀÌ Áõ°¡Çϰí ÀÖ½À´Ï´Ù.

Á¤¸Æ ½ºÅÙÆ®´Â ´ÏƼ³îÀ» ±â¹ÝÀ¸·Î ÇÑ ÀÚ°¡ È®ÀåÇü µðÀÚÀÎÀ¸·Î °³Å뼺, Á÷°æ ¹æÇ⼺, Á¤¸Æ ÇØºÎÇÐÀû ±¸Á¶¿¡ ´ëÇÑ ÀûÇÕ¼ºÀÌ °³¼±µÇ¾î º¯½ÅÀ» °ÅµìÇϰí ÀÖ½À´Ï´Ù. Ç÷Àü °ü¸®´Â Ä«Å×ÅÍ À¯µµ Ç÷Àü¿ëÇØ ¿ä¹ý(CDT), ÃÊÀ½ÆÄ º¸Á¶ Ç÷Àü¿ëÇØ ¿ä¹ý, ÈíÀÔ Ç÷ÀüÁ¦°Å¼ú·Î ¹ßÀüÇØ ¿ÔÀ¸¸ç, Ç÷Àü ºÎ´ã, ¿¹¹Î¼º, ÃâÇ÷ À§Çè¿¡ µû¶ó ´Ù¾çÇÑ ¼±ÅÃÁö°¡ Á¦°øµÇ°í ÀÖ½À´Ï´Ù. ½Ç½Ã°£ ¿µ»ó°ú AI ±â¹Ý ³»ºñ°ÔÀÌ¼Ç ½Ã½ºÅÛÀÇ ÅëÇÕÀº ÀÓ»óÀǰ¡ Ä¡·á ±¸¿ªÀ» º¸´Ù Á¤È®ÇÏ°Ô Á¼Çô ºÎ¼öÀûÀÎ Á¶Á÷ ¼Õ»óÀ» ÃÖ¼ÒÈ­ÇÒ ¼ö ÀÖµµ·Ï µ½°í ÀÖ½À´Ï´Ù. ¶ÇÇÑ, ÀÏȸ¿ë ¸ê±Õ ŰƮ¸¦ »ç¿ëÇÒ ¼ö ÀÖ°Ô µÊ¿¡ µû¶ó ¿öÅ©Ç÷ο찡 °£¼ÒÈ­µÇ¾î ÀÇ·á ÇöÀå Àü¹ÝÀÇ °¨¿° À§ÇèÀ» ÁÙÀÏ ¼ö ÀÖ°Ô µÇ¾ú½À´Ï´Ù.

Á¤¸Æ µð¹ÙÀ̽º »ç¿ëÀº ¾îµð¿¡¼­ Áõ°¡Çϰí ÀÖÀ¸¸ç, ¾î¶² ȯÀÚÃþÀÌ ¿ì¼±¼øÀ§¸¦ Â÷ÁöÇϰí Àִ°¡?

Á¤¸Æ ½Ã¼ú ±â±â´Â Àα¸ °í·ÉÈ­¿Í źźÇÑ »óȯ ü°è°¡ ³ôÀº ½Ã¼ú·®À» µÞ¹ÞħÇÏ´Â ºÏ¹Ì¿Í À¯·´¿¡¼­ ±¤¹üÀ§ÇÏ°Ô Ã¤Åõǰí ÀÖ½À´Ï´Ù. ¹Ì±¹¿¡¼­´Â CMSÀÇ ¿Ü·¡ ȯÀÚ ¿ì´ë Á¤Ã¥¿¡ ÈûÀÔ¾î »ç¹«½Ç ±â¹Ý ½ÇÇè½Ç(OBL)°ú ¿Ü·¡ ¼ö¼ú ¼¾ÅÍ(ASC)°¡ ÁÖ¿ä »ç¿ëÀÚÀÔ´Ï´Ù. ÀÌ º´¿øÀº ¶ÇÇÑ DVT ¹× Æó»öÀüÁõ ȯÀÚÀÇ ±Þ¼º ³úÁ¹Áß ¿¹¹æ ¿öÅ©Ç÷ο쿡 °í±Þ Ç÷ÀüÁ¦°Å ½Ã½ºÅÛÀ» »ç¿ëÇϰí ÀÖ½À´Ï´Ù. À¯·´¿¡¼­´Â µ¶ÀÏ, ¿µ±¹, ÇÁ¶û½º µîÀÇ ±¹°¡¿¡¼­ CVI¿Í VTE¿¡ ´ëÇÑ ÇÁ·ÎÅäÄÝÀ» Ç¥ÁØÈ­Çϰí ÀÖ¾î ÀϰüµÈ ±â±â ¼ö¿ä°¡ ÀÖ½À´Ï´Ù.

¶óƾ¾Æ¸Þ¸®Ä«, Áßµ¿, ¾Æ½Ã¾ÆÅÂÆò¾ç ½ÅÈï½ÃÀå¿¡¼­´Â ½ÉÇ÷°ü °ËÁø Áõ°¡, ÀÇ·á°ü±¤ ÀÎÇÁ¶ó ±¸Ãà, ÀÏÂ÷ Áø·áÀÇ»çÀÇ ÀÎ½Ä Á¦°í µîÀ» ¹è°æÀ¸·Î Á¤¸Æ ½Ã¼úÀÌ Áõ°¡Çϰí ÀÖ½À´Ï´Ù. Àεµ¿Í µ¿³²¾Æ½Ã¾Æ¿¡¼­´Â ºñ¿ë È¿À²ÀûÀÎ Á¤¸Æ ¼ÒÀÛ Å°Æ®¿Í °Åǰ °æÈ­¿ä¹ý ½Ã½ºÅÛÀ» ÅëÇØ ÀÇ·á ¼­ºñ½º¸¦ Á¦´ë·Î Á¦°ø¹ÞÁö ¸øÇÏ´Â ³óÃÌ Áö¿ª ÁֹεéÀ» À§ÇÑ ´ë±Ô¸ð Ä¡·á Ä·ÆäÀÎÀÌ °¡´ÉÇØÁ³½À´Ï´Ù. Áß¿äÇÑ ÃÊÁ¡Àº 40¼¼ ÀÌ»óÀÇ ¿©¼ºÀ̸ç, ÀÌ °èÃþÀº È£¸£¸ó º¯È­, Á÷¾÷Àû ÁöÀ§, ÀӽŰú °ü·ÃµÈ Á¤¸Æ ½ºÆ®·¹½º·Î ÀÎÇØ Á¤¸Æ·ù¿Í CVIÀÇ ¿µÇâÀ» ºÒ±ÕÇüÀûÀ¸·Î ¹Þ°í ÀÖ½À´Ï´Ù. ÀÌ °èÃþÀº °íÀ§Çè ¼ö¼ú ÈÄ È¯ÀÚ ¹× Á¾¾ç ȯÀÚ¿Í ÇÔ²² ¿ì¼±¼øÀ§°¡ ³ôÀº ºÎ¹®À» ±¸¼ºÇϰí ÀÖ½À´Ï´Ù.

Á¤¸Æ ½Ã¼ú ±â±â ¼¼°è ½ÃÀå ¼ºÀåÀ» ÁÖµµÇÏ´Â ¿äÀÎÀº ¹«¾ùÀϱî?

Á¤¸Æ ½Ã¼ú ±â±â ½ÃÀåÀÇ ¼ºÀåÀº Á¤¸Æ ÁúȯÀÇ ºÎ´ã Áõ°¡, ¿Ü·¡ ȯÀÚ¿¡¼­ ÃÖ¼Òħ½ÀÀû Ä¡·á·ÎÀÇ Àüȯ, È¿°ú¿Í ¾ÈÀü¼ºÀ» ¸ðµÎ Çâ»ó½ÃŰ´Â ±â¼ú ¹ßÀü µî ¿©·¯ °¡Áö ¿äÀο¡ ÀÇÇØ ÀÌ·ç¾îÁý´Ï´Ù. ÀÇ·áÁøÀº ¸¸¼º Á¤¸Æ Áúȯ¿¡ ´ëÇÑ Á¶±â °³ÀÔÀ» ¿ì¼±¼øÀ§¿¡ µÎ°í ÀÔ¿øÀ» ÁÙÀ̰í, ¿îµ¿ ´É·ÂÀ» Çâ»ó½Ã۸ç, Æó»öÀüÁõ°ú °°Àº »ý¸íÀ» À§ÇùÇÏ´Â ÇÕº´ÁõÀ» ¿¹¹æÇϱâ À§ÇØ ³ë·ÂÇϰí ÀÖ½À´Ï´Ù. °í·ÉÈ­, ´ç´¢º´, ºñ¸¸ÀÇ Áõ°¡µµ Áß¿äÇÑ ¿øµ¿·ÂÀÌ µÇ°í ÀÖ½À´Ï´Ù.

Ä¡·á ±â±âÀÇ ¼ÒÇüÈ­, ¿¡³ÊÁö Àü´Þ Ç÷§ÆûÀÇ °­È­, ÃÖ¼Ò ÆÄ±«Àû Ä¡·á¿¡ ´ëÇÑ È¯ÀÚµéÀÇ ¼±È£µµ°¡ ³ô¾ÆÁö¸é¼­ ¾÷°è´Â Áö¼ÓÀûÀÎ ±â¼ú Çõ½Å¿¡ ¹ÚÂ÷¸¦ °¡Çϰí ÀÖ½À´Ï´Ù. À¯¸®ÇÑ ¼ö°¡ Á¤Ã¥, Àü¹®ºÐ¾ß¸¦ ÃÊ¿ùÇÑ Çù·Âü°è, ÇÏÀ̺긮µå Ç÷°ü¼¾ÅÍÀÇ º¸±ÞÀ¸·Î ½Ã¼ú¿¡ ´ëÇÑ Á¢±Ù¼ºÀÌ È®´ëµÇ°í ÀÖ½À´Ï´Ù. ¶ÇÇÑ, ±³À° ÀÌ´Ï¼ÅÆ¼ºê¿Í CME ÇÁ·Î±×·¥Àº ½ÅÈï ½ÃÀåÀÇ ÀÇ»çµéÀÌ °í±Þ Á¤¸Æ Ä¡·á¸¦ Á¦°øÇÒ ¼ö ÀÖ´Â ±â¼ú°ú ÇÁ·ÎÅäÄÝÀ» ½ÀµæÇÒ ¼ö ÀÖµµ·Ï µ½°í ÀÖ½À´Ï´Ù. ½Ã¼ú °Ç¼ö°¡ Áõ°¡ÇÏ°í µðÁöÅÐ ½ºÅ©¸®´× ÅøÀ» ÅëÇØ »õ·Î¿î ȯÀÚ±ºÀÌ È®Àεʿ¡ µû¶ó Á¤¸Æ ½Ã¼ú ±â±â ½ÃÀåÀº ÀÓ»óÀû, Áö¸®Àû, ¼ÒºñÀÚ Â÷¿ø¿¡¼­ Áö¼ÓÀûÀ¸·Î È®´ëµÉ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù.

ºÎ¹®

Á¦Ç° À¯Çü(Ä«Å×ÅÍ, °¡À̵å¿ÍÀ̾î, ±âŸ Á¦Ç° À¯Çü), Áúȯ(Ç÷°üÁúȯ, ¾Ï Áúȯ), ¿ëµµ(ÇÏÁö ¿ëµµ, ÈäºÎ ¿ëµµ, º¹ºÎ ¿ëµµ, ¿ÏºÎ ¿ëµµ), ÃÖÁ¾»ç¿ëÀÚ(º´¿ø ÃÖÁ¾»ç¿ëÀÚ, ¿Ü·¡ ¼ö¼ú ¼¾ÅÍ ÃÖÁ¾»ç¿ëÀÚ, Àü¹® Ŭ¸®´Ð ÃÖÁ¾»ç¿ëÀÚ, ±âŸ ÃÖÁ¾»ç¿ëÀÚ)

Á¶»ç ´ë»ó ±â¾÷ »ç·Ê

AI ÅëÇÕ

Global Industry Analysts´Â °ËÁõµÈ Àü¹®°¡ ÄÁÅÙÃ÷¿Í AI ÅøÀ» ÅëÇØ ½ÃÀå Á¤º¸¿Í °æÀï Á¤º¸¸¦ Çõ½ÅÇϰí ÀÖ½À´Ï´Ù.

Global Industry Analysts´Â ÀϹÝÀûÀÎ LLM ¹× ¾÷°èº° SLM Äõ¸®¸¦ µû¸£´Â ´ë½Å ºñµð¿À ±â·Ï, ºí·Î±×, °Ë»ö ¿£Áø Á¶»ç, ¹æ´ëÇÑ ¾çÀÇ ±â¾÷, Á¦Ç°/¼­ºñ½º, ½ÃÀå µ¥ÀÌÅÍ µî ¼¼°è Àü¹®°¡·ÎºÎÅÍ ¼öÁýÇÑ ÄÁÅÙÃ÷ ¸®Æ÷ÁöÅ丮¸¦ ±¸ÃàÇß½À´Ï´Ù.

°ü¼¼ ¿µÇâ °è¼ö

Global Industry Analysts´Â º»»ç ¼ÒÀçÁö, Á¦Á¶°ÅÁ¡, ¼öÃâÀÔ(¿ÏÁ¦Ç° ¹× OEM)À» ±âÁØÀ¸·Î ±â¾÷ÀÇ °æÀï·Â º¯È­¸¦ ¿¹ÃøÇϰí ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ º¹ÀâÇÏ°í ´Ù¸éÀûÀÎ ½ÃÀå ¿ªÇÐÀº ¸ÅÃâ¿ø°¡(COGS) Áõ°¡, ¼öÀͼº Ç϶ô, °ø±Þ¸Á ÀçÆí µî ¹Ì½ÃÀû, °Å½ÃÀû ½ÃÀå ¿ªÇÐ Áß¿¡¼­µµ ƯÈ÷ °æÀï»çµé¿¡°Ô ¿µÇâÀ» ¹ÌÄ¥ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù.

¸ñÂ÷

Á¦1Àå Á¶»ç ¹æ¹ý

Á¦2Àå ÁÖ¿ä ¿ä¾à

Á¦3Àå ½ÃÀå ºÐ¼®

Á¦4Àå °æÀï

KSM
¿µ¹® ¸ñÂ÷

¿µ¹®¸ñÂ÷

Global Venous Procedure Devices Market to Reach US$3.7 Billion by 2030

The global market for Venous Procedure Devices estimated at US$2.6 Billion in the year 2024, is expected to reach US$3.7 Billion by 2030, growing at a CAGR of 5.7% over the analysis period 2024-2030. Catheters, one of the segments analyzed in the report, is expected to record a 6.7% CAGR and reach US$2.3 Billion by the end of the analysis period. Growth in the Guidewires segment is estimated at 3.9% CAGR over the analysis period.

The U.S. Market is Estimated at US$718.5 Million While China is Forecast to Grow at 9.2% CAGR

The Venous Procedure Devices market in the U.S. is estimated at US$718.5 Million in the year 2024. China, the world's second largest economy, is forecast to reach a projected market size of US$749.2 Million by the year 2030 trailing a CAGR of 9.2% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 2.7% and 5.6% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 3.7% CAGR.

Global Venous Procedure Devices Market - Key Trends & Drivers Summarized

Why Are Venous Procedure Devices Experiencing Elevated Demand Across Multiple Specialties?

Venous procedure devices, encompassing technologies used in the treatment of chronic venous insufficiency (CVI), deep vein thrombosis (DVT), varicose veins, and venous ulcers, are experiencing a demand resurgence due to demographic aging, sedentary lifestyles, and rising incidence of vascular disorders. These devices include radiofrequency and laser ablation catheters, sclerotherapy kits, venous stents, thrombectomy devices, and compression systems, all of which support minimally invasive interventions aimed at improving venous return and preventing complications. Clinical uptake is expanding across vascular surgery, interventional radiology, and dermatology practices.

A particularly strong growth driver is the rising prevalence of venous thromboembolism (VTE), a leading cause of preventable death in hospitals worldwide. The increasing use of diagnostic imaging, awareness of post-thrombotic syndrome (PTS), and improved referral pathways are expanding the treatable patient pool. Parallel to this, advancements in office-based procedures and outpatient settings are driving demand for portable, image-guided ablation systems and disposable catheter kits. Consumer-driven aesthetics and quality-of-life concerns are also pushing demand for cosmetic varicose vein removal, further broadening the clinical landscape for venous devices.

How Are Innovations in Device Design Enhancing Procedural Efficiency and Outcomes?

Technology evolution in venous procedure devices is focused on improving patient comfort, reducing recurrence rates, and enabling rapid recovery. Next-generation endovenous ablation systems use bipolar radiofrequency and fiber-delivered laser energy for precision thermal closure of incompetent veins, with integrated cooling and feedback mechanisms to minimize thermal injury. Mechanochemical ablation (MOCA) systems, which combine mechanical irritation with sclerosant infusion, are gaining adoption for their non-thermal, anesthesia-free benefits and suitability in tortuous venous anatomy.

Venous stents are witnessing a transformation, with nitinol-based self-expanding designs offering improved patency, radial force, and conformity to the venous anatomy. Thrombus management has advanced through catheter-directed thrombolysis (CDT), ultrasonic-assisted thrombolysis, and aspiration thrombectomy, offering options tailored to clot burden, acuity, and bleeding risk. The integration of real-time imaging and AI-powered navigation systems is helping clinicians better target treatment zones and minimize collateral tissue damage. Moreover, the increased availability of single-use, sterile kits is streamlining workflow and reducing infection risk across care settings.

Where Is Utilization of Venous Devices Rising and What Patient Segments Are Being Prioritized?

Venous procedure devices are witnessing widespread adoption in North America and Europe, where aging populations and robust reimbursement frameworks support high procedure volumes. In the U.S., office-based labs (OBLs) and ambulatory surgical centers (ASCs) are key users, supported by CMS policies favoring outpatient interventions. Hospitals are also using advanced thrombectomy systems in acute stroke prevention workflows for patients presenting with DVT or pulmonary embolism. In Europe, countries such as Germany, the UK, and France have standardized protocols for CVI and VTE, resulting in consistent device demand.

Emerging markets in Latin America, the Middle East, and Asia-Pacific are seeing a rise in venous procedures driven by increased cardiovascular screening, improved medical tourism infrastructure, and growing awareness among primary care physicians. In India and Southeast Asia, cost-effective venous ablation kits and foam sclerotherapy systems are enabling large-scale treatment campaigns for underserved rural populations. A key focus is on women over 40, a group disproportionately affected by varicose veins and CVI due to hormonal changes, occupational standing, and pregnancy-related venous stress. This demographic, along with high-risk post-surgical and oncology patients, constitutes a high-priority segment.

What Is Driving Growth in the Global Venous Procedure Devices Market?

The growth in the venous procedure devices market is driven by several factors, including the increasing burden of venous diseases, the shift toward outpatient minimally invasive interventions, and the advancement of technology that improves both efficacy and safety. Healthcare providers are prioritizing early intervention in chronic venous disorders to reduce hospitalizations, improve mobility, and prevent life-threatening complications like pulmonary embolism. The global rise in aging populations, diabetes, and obesity are also significant underlying drivers.

Device miniaturization, enhanced energy delivery platforms, and growing patient preference for minimally disruptive treatment are pushing the industry toward continuous innovation. Favorable reimbursement policies, cross-specialty collaboration, and the proliferation of hybrid vascular centers are expanding procedural access. Additionally, training initiatives and CME programs are equipping physicians in emerging markets with the skills and protocols to deliver advanced venous care. With procedural volumes rising and new patient populations being identified through digital screening tools, the venous procedure devices market is set for sustained expansion across clinical, geographic, and consumer dimensions.

SCOPE OF STUDY:

The report analyzes the Venous Procedure Devices market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:

Product Type (Catheters, Guidewires, Other Product Types); Disease (Vascular Disease, Cancer Disease); Application (Leg Application, Chest Application, Abdomen Application, Arm Application); End-User (Hospitals End-User, Ambulatory Surgery Centers End-User, Specialty Clinics End-User, Other End-Users)

Geographic Regions/Countries:

World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; Spain; Russia; and Rest of Europe); Asia-Pacific (Australia; India; South Korea; and Rest of Asia-Pacific); Latin America (Argentina; Brazil; Mexico; and Rest of Latin America); Middle East (Iran; Israel; Saudi Arabia; United Arab Emirates; and Rest of Middle East); and Africa.

Select Competitors (Total 42 Featured) -

AI INTEGRATIONS

We're transforming market and competitive intelligence with validated expert content and AI tools.

Instead of following the general norm of querying LLMs and Industry-specific SLMs, we built repositories of content curated from domain experts worldwide including video transcripts, blogs, search engines research, and massive amounts of enterprise, product/service, and market data.

TARIFF IMPACT FACTOR

Our new release incorporates impact of tariffs on geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by increasing the Cost of Goods Sold (COGS), reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

III. MARKET ANALYSIS

IV. COMPETITION

(ÁÖ)±Û·Î¹úÀÎÆ÷¸ÞÀÌ¼Ç 02-2025-2992 kr-info@giikorea.co.kr
¨Ï Copyright Global Information, Inc. All rights reserved.
PC¹öÀü º¸±â